Novavax Faces New Challenges for Full COVID Vaccine Approval in the U.S.

​The U.S. Food and Drug Administration (FDA) has requested that Novavax conduct an additional clinical trial to obtain full approval for its COVID-19 vaccine. This request comes despite the vaccine’s prior demonstration of 90% efficacy in a 30,000-participant trial and its existing emergency use authorization in the U.S. The vaccine has already received full approval…

Read More

Why Bitcoin Mining Is No Longer Worth It

In its early days, Bitcoin mining was a profitable opportunity for individuals with powerful computers and access to cheap electricity. However, over the years, the process has become increasingly unaffordable for everyday miners. Today, there are several strong reasons why mining Bitcoin is no longer worth it for most people. High Competition and Specialized Equipment…

Read More

Border Closures and Trade Restrictions Escalate Amid Foot-and-Mouth Disease Outbreak

The foot-and-mouth disease outbreak continues to spread across Europe, prompting heightened measures and international concern. Austria has closed 24 border crossings with Hungary and Slovakia, while Slovakia has declared a state of emergency and secured 10,000 vaccine doses to combat the virus.The outbreak, which began in Hungary in early March, has now affected multiple farms…

Read More
Back To Top